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Abstract
We report a case of incidental uptake of 99mTc-methylene diphosphonate in the thyroid in a 62-year-old female with a history 
of breast cancer treated with quadrantectomy, chemotherapy and radiotherapy, who underwent total-body-bone scintigraphy 
during follow up. Planar scintigraphy was followed by neck SPECT-CT that demonstrated an area of increased tracer uptake 
in the neck at the left lobe of the thyroid. Neck ultrasonography showed a nodule corresponding to SPECT-CT finding and 
the ultrasound-guided fine needle aspiration documented the presence of papillary carcinoma. The patient underwent total 
thyroidectomy and ipsilateral lymphadenectomy; histological examination confirmed the presence of a papillary carcinoma 
and the patient underwent ablation therapy with iodine-131.
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Background
99mTc-MDP bone scintigraphy is a nuclear scanning test to find 
certain abnormalities in bone. It is mainly used to help diagnose 
a number of conditions related to bones, including primary bony 
malignancies, metastatic diseases that have spread to the bone, 
occult fractures and other conditions. In addition, this examination 
is often used for the follow up or response to treatment of some 
solid cancers like prostate and breast cancers [1]. Besides, the 
bone scan delineates a wide spectrum of non-osseous disorders: 
neoplastic, hormonal, inflammatory, ischemic, traumatic, excre-
tory and artifactual entities may demonstrate abnormal soft tissue 
uptake of 99mTc-MDP [2].
Case report
A 62-years-old female with a history of breast cancer (invasive 
ductal carcinoma) previously treated with quadrantectomy with 
axillary dissection, chemotherapy and radiotherapy underwent 
99mTc-methylene diphosphonate (MDP) bone scintigraphy during 
the follow-up in order to verify the presence of skeletal metastases. 
The study was negative for bone metastases but revealed an area 
of focal tracer uptake at the base of the neck more visible in the 
anterior view (Figure 1-A, 1-B), corresponding to the left lobe of the 
thyroid gland at the subsequent single-photon emission computed 
tomography-computed tomography (SPECT-CT) acquisition of the 
neck and thorax (Figure 1-C). CT images revealed a 2 cm solid 
roundish nodule. The neck ultrasonography showed a solid nodule 
in the left lobe of the thyroid, almost entirely calcified mainly in the 
capsule with a diameter of 2 cm. Ultrasound-guided fine needle as-
piration (FNA) was positive for papillary carcinoma (TIR6 Bethesda 
system). The patient underwent total thyroidectomy associated 
with ispilateral lymphadenectomy. Histological examination of the 
primary tumor revealed a conventional papillary carcinoma with 
thyroid capsule invasion and extrathyroidal extension with two left 
lateral cervical metastatic nodes (pT3N1a AJCC 2010 classifica-
tion). Therefore, after the withdrawal of thyroid hormone therapy, she 
underwent iodine-131 (I131) therapy (3.7 GBq) for remnant ablation. 
After 72 hours the I131 total body planar scintigraphy (Figure 2-A) 
and the subsequent SPECT/CT of neck and thorax (Figure 2-B1–B3) 
showed high focal uptake of tracer in the upper central area of the 
neck due to thyroglossal duct remnant and slight uptake in left 
thyroid bed corresponding to residual thyroid tissue.
Discussion
In literature many cases of incidental uptakes of 99mTc-MDP 
at extraosseous sites have been reported: neoplastic, hormonal, 
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inflammatory, ischemic, traumatic, excretory and artifactual enti-
ties may demonstrate abnormal soft tissue uptake of 99mTc-MDP [2].
Radionuclide imaging with 99mTc-MDP generally depends on 
the uptake of the tracer by normal osteoblasts reacting to bone 
damage produced by malignant lesions. However in certain dis-
orders, especially those characterized by soft tissue calcification, 
the radiopharmaceutical may accumulate within pathologic tissue 
itself. 99mTc-MDP thyroid incidental uptake is not very frequent 
and it is possibly caused by the presence of calcification [3, 4], 
biopsy procedure [5], anaplastic carcinoma [6] or metastatic 
calcifications in patients affected by primary hyperparathyroidism 
[7]. It can also happen to have focal tracer uptake in the thyroid 
autonomous nodules that is probably caused by dissociation 
of 99mTc from MDP. Calcified nodules may show high uptake of 
this radiopharmaceutical. Calcification within the thyroid may hap-
pen in both benign and malignant diseases [8]. It is well known 
Figure 1A–C. In this figure 99mTc-methylene diphosphonate (MDP) bone scintigraphy is showed;  
1-A. Anterior and posterior views of the study showing the lesion (black arrow); 1-B. An enlargement of 
the previous study to show more clearly the lesion in the neck; 1-C. An acquisition of the neck and thorax 
of single-photon emission computed tomography-computed tomography (SPECT-CT)
Figure 2–A. Anterior and posterior view of I131 total body scintigraphy performed in the patient after 
radiometabolic therapy that showed focal uptake of tracer in the upper central area of the neck due to 
thyroglossal duct remnant (slim arrow) and slight uptake in left thyroid bed corresponding to residual 
parenchymal (empty arrow); 2-B1–B3. Axial, coronal and sagittal I131 SPECT-TC fused images
1-A
1-B 1-C
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that microcalcifications are associated with thyroid malignancy [9]; 
instead the association between macrocalcifications and thyroid 
cancer remains still under discussion but it is mainly related to 
benign disease [10, 11].
The peculiarity of this report is that the finding of a nodule 
entirely calcified is associated with malignancy, although in clinical 
practice it is usually associated with benign disease. In conclusion, 
this report underlines the importance of further investigation of inci-
dental findings in the thyroid at 99mTc-MDP bone scan, potentially of 
clinical relevance and pivotal for an adequate patient management.
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